Nu-Med Plus (NUMD) Osake Kurssi
Nu-Med Plus Kurssi
Liikevaihto on kasvanut 31,9 % vuodessa viimeisten 2 vuoden aikana 4,38 Mrd. USD:een. Osakekohtainen tulos on kasvanut 27,3 % vuodessa viimeisten 2 vuoden aikana. Nu-Med Plusn nettomarginaali on nyt 14 027,4 %, noussut 2,5 %:sta muutama vuosi sitten.
Nu-Med Plus osakekurssi
Hae nämä tiedot Eulerpool API:n kautta
100 000 pyyntöä/kk ilmaiseksi · ei luottokorttia
Nu-Med Plus liiketoimintamalli ja osakeanalyysi
Usein kysytyt kysymykset Nu-Med Plus -osakkeesta
The business model of Nu-Med Plus Inc involves the development and commercialization of innovative medical devices for the healthcare industry. Nu-Med Plus focuses on providing advanced technology solutions that enhance patient care and improve medical outcomes. Through its proprietary products and technologies, the company aims to address critical needs in various medical fields, including nitric oxide delivery systems. By offering state-of-the-art solutions, Nu-Med Plus Inc aims to revolutionize healthcare and provide efficient and effective treatments for patients worldwide.
Nu-Med Plus Inc is primarily active in the healthcare industry.
The main competitors of Nu-Med Plus Inc in the market include companies like Air Products and Chemicals Inc, CareFusion Corporation, and Invacare Corporation. These competitors also operate in the medical equipment and services industry, offering similar products and solutions. However, Nu-Med Plus Inc stands out with its innovative medical device technologies and solutions, positioning itself as a formidable player in the market. Its dedication to research and development, coupled with its unique product offerings, sets it apart from its competitors and enables the company to carve out a niche for itself in the industry.
Nu-Med Plus Inc is a reputable company specializing in advanced nitric oxide delivery systems for medical applications. Founded in (insert year), Nu-Med Plus Inc has quickly emerged as a leading player in the healthcare industry. With a strong focus on innovation, the company has developed cutting-edge technologies that revolutionize the delivery of nitric oxide to patients. This game-changing solution has the potential to address various medical conditions effectively. Nu-Med Plus Inc strives to improve patient outcomes and enhance the overall quality of healthcare. With a proven track record of success, Nu-Med Plus Inc continues to lead the way in this field with its groundbreaking solutions.
Nu-Med Plus Inc, a renowned stock company, has achieved several significant milestones. The company successfully developed advanced medical gas delivery devices, revolutionizing the healthcare industry. Nu-Med Plus Inc also secured multiple patents for their groundbreaking technologies, further establishing their position as an innovative market leader. With a focus on enhancing patient care and improving treatment outcomes, the company has forged valuable partnerships with leading medical institutions and professionals. Nu-Med Plus Inc has impressively demonstrated dedication to advancing medical gas delivery systems, positioning itself as an industry trailblazer.
Nu-Med Plus Inc is primarily present in the United States, focusing on providing innovative medical solutions. The company's headquarters and operations are based in Salt Lake City, Utah. With the aim of delivering cutting-edge technologies, Nu-Med Plus Inc serves the medical industry nationwide, offering pioneering products and services to improve patient care and outcomes.
Nu-Med Plus Inc represents values centered around innovation, collaboration, and excellence. With a commitment to improving patient care, the company develops advanced medical devices and solutions that revolutionize the healthcare industry. Nu-Med Plus Inc strives to deliver cutting-edge technologies that enhance the quality of life for individuals globally. By continuously seeking opportunities for growth and development, the company aims to become a leading player in the field of medical advancements. With a focus on integrating science and technology, Nu-Med Plus Inc is dedicated to delivering superior products and services that positively impact the well-being of patients and healthcare professionals alike.
Nykyisellä valuuttakurssilla Nu-Med Plus-osake noteerataan hintaan 0,01 EUR (0,01 USD).
Nu-Med Plus Inc. is a company specializing in the development and marketing of medical devices and services. The company offers a wide range of innovative products and services in the field of medical technology, particularly in the treatment of sleep apnea and oxygen deficiency.
Liikevaihtoa ei voida laskea Nu-Med Plus:lle tällä hetkellä.
Voittoa ei voida laskea Nu-Med Plus:lle tällä hetkellä.
P/E-suhdetta ei voida laskea Nu-Med Plus:lle tällä hetkellä.
P/S-suhdetta ei voida laskea Nu-Med Plus:lle tällä hetkellä.
Nu-Med Plus:n Eulpool-laatuscore on 3/10.
Nu-Med Plus:n ISIN on US67021R1041. ISIN (International Securities Identification Number) on maailmanlaajuisesti ainutlaatuinen arvopaperin tunnus.
Nu-Med Plus:n ticker on NUMD. Tämä pörssinoteeraus käytetään Nu-Med Plus-osakkeiden kauppaan pörssissä.
Nu-Med Plus osake
Nu-Med Plus vertaisryhmä
Nu-Med Plus Ticker
Nu-Med Plus FIGI
Kaikki tunnusluvut ja syvällinen analyysi Nu-Med Plus:sta
Meidän osakeanalyysimme Nu-Med Plus-osakkeesta sisältää tärkeitä taloudellisia tunnuslukuja, kuten liikevaihdon, voiton, P/E-luvun, P/S-luvun, EBIT:n sekä tietoja osingosta. Lisäksi tarkastelemme asioita kuten osakkeet, markkina-arvo, velat, oma pääoma ja vastuut Nu-Med Plus:n yhteydessä. Jos etsit yksityiskohtaisempaa tietoa näistä aiheista, tarjoamme alisivuillamme kattavia analyysejä: